Skip to content
April 16, 2024

Equity.Guru

Investment information for the new generation

Search

Health Science

Counting Sheep   For me, sleeping is both a blessing and a curse. While I love nothing more than laying in bed after a long day, I hate waking…
Kezar Life Sciences Inc. $561.261M Market Capitalization Between 2020 and 2021, year-over-year (YoY) funding in the biotech market increased by an impressive 39.6%. Currently, some of the biggest trends…
Last year Big Pharma unleashed 1,500 lobbyists to Washington, DC, who then cut cheques for $177 million to keep drug costs high. The lobbyists deserve bonuses. The average U.S….
Special Delivery $19.043M Market Capitalization Lexaria Bioscience Corp. (LEXX.Q) is a biotechnology company developing DehydraTECH™, the Company’s proprietary drug delivery technology. In addition to enhancing the speed and efficiency of…
Eye Don’t Believe It   Fill Disclosure: weekly roundups are intended to provide a quick introduction to various companies. They are not intended to be deep dives or opinion…
Sixth Wave Innovations (SIXW.C) announced it had shipped its Discovery Affinity system to Retro Cannabis and Hemp Extracts pursuant to an LOI announced on May 19, 2022. The system…
Battling cancer has always been about timing, catch it early enough and you are better positioned for victory. Unfortunately traditional diagnosis is dependent on the physical discovery of cancerous…
Closing the Diabetic Loop Before we get into this week’s sector roundup, let’s talk about diabetes. I am a sucker for sweets, so much so that I was diagnosed…
This year hasn’t been particularly good for the markets. The decline over the past year has been brutal, including volatility on major indexes, inflation hikes and of course the…
Repare Therapeutics (RPTX) is a leading clinical-stage precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its…